Cholesterol depletion reduces entry of Campylobacter jejuni cytolethal distending toxin and attenuates intoxication of host cells

Infection and Immunity

Volumn 79, Issue 9, 2011, Pages 3563-3575

  Lin, Chia Der ^a,g   Lai, Cheng Kuo ^b   Lin, Yu Hsin ^c   Hsieh, Jer Tsong ^d   Sing, Yu Ting ^a   Chang, Yun Chieh ^e   Chen, Kai Chuan ^f   Wang, Wen Ching ^e   Su, Hong Lin ^b   Lai, Chih Ho ^a,d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^f INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^g CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CYTOLETHAL DISTENDING TOXIN;

ANIMAL CELL; ARTICLE; BACTERIAL VIRULENCE; CAMPYLOBACTER JEJUNI; CELL CYCLE ARREST; CELL MEMBRANE; HOST CELL; LIPID RAFT; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BACTERIAL TOXINS; BETA-CYCLODEXTRINS; CAMPYLOBACTER JEJUNI; CELL CYCLE; CELL LINE, TUMOR; CELL MEMBRANE; CHO CELLS; CHOLESTEROL; CRICETINAE; CRICETULUS; FLOW CYTOMETRY; HUMANS; MEMBRANE MICRODOMAINS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; VIRULENCE FACTORS;

EID: 80052328306     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05175-11     Document Type: Article

References (59)

1. Abrami, L., S. Liu, P. Cosson, S. H. Leppla, and F. G. van der Goot. 2003. Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process. J. Cell Biol. 160:321-328.
2. Bag, P. K., T. Ramamurthy, and U. B. Nair. 1993. Evidence for the presence of a receptor for the cytolethal distending toxin (CLDT) of Campylobacter jejuni on CHO and HeLa cell membranes and development of a receptorbased enzyme-linked immunosorbent assay for detection of CLDT. FEMS Microbiol. Lett. 114:285-291.
3. Baus, F., V. Gire, D. Fisher, J. Piette, and V. Dulic. 2003. Permanent cell cycle exit in G2 phase after DNA damage in normal human fibroblasts. EMBO J. 22:3992-4002.
4. Blaser, M. J., R. E. Black, D. J. Duncan, and J. Amer. 1985. Campylobacter jejuni-specific serum antibodies are elevated in healthy Bangladeshi children. J. Clin. Microbiol. 21:164-167.
5. Boesze-Battaglia, K., et al. 2006. Cholesterol-rich membrane microdomains mediate cell cycle arrest induced by Actinobacillus actinomycetemcomitans cytolethal-distending toxin. Cell Microbiol. 8:823-836.
6. Boesze-Battaglia, K., et al. 2009. Cytolethal distending toxin-induced cell cycle arrest of lymphocytes is dependent upon recognition and binding to cholesterol. J. Biol. Chem. 284:10650-10658.
7. Bouzari, S., and A. Varghese. 1990. Cytolethal distending toxin (CLDT) production by enteropathogenic Escherichia coli (EPEC). FEMS Microbiol. Lett. 59:193-198.
8. Brown, D., and G. L. Waneck. 1992. Glycosyl-phosphatidylinositol-anchored membrane proteins. J. Am. Soc. Nephrol. 3:895-906.
9. Brown, D. A., and E. London. 1998. Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 14:111-136.
10. Butzler, J. P., and M. B. Skirrow. 1979. Campylobacter enteritis. Clin. Gastroenterol. 8:737-765.
11. Cao, L., A. Volgina, C. M. Huang, J. Korostoff, and J. M. DiRienzo. 2005. Characterization of point mutations in the cdtA gene of the cytolethal distending toxin of Actinobacillus actinomycetemcomitans. Mol. Microbiol. 58: 1303-1321.
12. Cope, L. D., et al. 1997. A diffusible cytotoxin of Haemophilus ducreyi. Proc. Natl. Acad. Sci. U. S. A. 94:4056-4061.
13. Corry, J. E., and H. I. Atabay. 2001. Poultry as a source of Campylobacter and related organisms. Symp. Ser. Soc. Appl. Microbiol. 2001:96S-114S.
14. Duncan, M. J., G. Li, J. S. Shin, J. L. Carson, and S. N. Abraham. 2004. Bacterial penetration of bladder epithelium through lipid rafts. J. Biol. Chem. 279:18944-18951.
15. Eshraghi, A., et al. 2010. Cytolethal distending toxin family members are differentially affected by alterations in host glycans and membrane cholesterol. J. Biol. Chem. 285:18199-18207.
16. Farrand, A. J., S. LaChapelle, E. M. Hotze, A. E. Johnson, and R. K. Tweten. 2010. Only two amino acids are essential for cytolytic toxin recognition of cholesterol at the membrane surface. Proc. Natl. Acad. Sci. U. S. A. 107: 4341-4346.
17. Gauthier, N. C., et al. 2005. Helicobacter pylori VacA cytotoxin: a probe for a clathrin-independent and Cdc42-dependent pinocytic pathway routed to late endosomes. Mol. Biol. Cell 16:4852-4866.
18. Goswami, R., D. Singh, G. Phillips, J. Kilkus, and G. Dawson. 2005. Ceramide regulation of the tumor suppressor phosphatase PTEN in rafts isolated from neurotumor cell lines. J. Neurosci. Res. 81:541-550.
19. Guerra, L., et al. 2005. Cellular internalization of cytolethal distending toxin: a new end to a known pathway. Cell. Microbiol. 7:921-934.
20. Hickey, T. E., et al. 2000. Campylobacter jejuni cytolethal distending toxin mediates release of interleukin-8 from intestinal epithelial cells. Infect. Immun. 68:6535-6541.
21. Hooper, N. M. 1999. Detergent-insoluble glycosphingolipid/cholesterol-rich membrane domains, lipid rafts and caveolae (review). Mol. Membr. Biol. 16:145-156.
22. Johnson, W. M., and H. Lior. 1988. A new heat-labile cytolethal distending toxin (CLDT) produced by Campylobacter spp. Microb. Pathog. 4:115-126.
23. Kuo, C. H., and W. C. Wang. 2003. Binding and internalization of Helicobacter pylori VacA via cellular lipid rafts in epithelial cells. Biochem. Biophys. Res. Commun. 303:640-644.
24. Lafont, F., G. Tran Van Nhieu, K. Hanada, P. Sansonetti, and F. G. van der Goot. 2002. Initial steps of Shigella infection depend on the cholesterol/ sphingolipid raft-mediated CD44-IpaB interaction. EMBO J. 21:4449-4457.
25. Lai, C. H., et al. 2008. Cholesterol depletion reduces Helicobacter pylori CagA translocation and CagA-induced responses in AGS cells. Infect. Immun. 76:3293-3303.
26. Lara-Tejero, M., and J. E. Galan. 2000. A bacterial toxin that controls cell cycle progression as a DNase I-like protein. Science 290:354-357.
27. Lara-Tejero, M., and J. E. Galan. 2001. CdtA, CdtB, and CdtC form a tripartite complex that is required for cytolethal distending toxin activity. Infect. Immun. 69:4358-4365.
28. Lara-Tejero, M., and J. E. Galan. 2002. Cytolethal distending toxin: limited damage as a strategy to modulate cellular functions. Trends Microbiol. 10:147-152.
29. Li, H., and V. Papadopoulos. 1998. Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern. Endocrinology 139:4991-4997.
30. Maehama, T., and J. E. Dixon. 1999. PTEN: a tumour suppressor that functions as a phospholipid phosphatase. Trends Cell Biol. 9:125-128.
31. Mao, X., and J. M. DiRienzo. 2002. Functional studies of the recombinant subunits of a cytolethal distending holotoxin. Cell Microbiol. 4:245-255.
32. Mayer, M. P., L. C. Bueno, E. J. Hansen, and J. M. DiRienzo. 1999. Identification of a cytolethal distending toxin gene locus and features of a virulence-associated region in Actinobacillus actinomycetemcomitans. Infect. Immun. 67:1227-1237.
33. McSweeney, L. A., and L. A. Dreyfus. 2005. Carbohydrate-binding specificity of the Escherichia coli cytolethal distending toxin CdtA-II and CdtC-II subunits. Infect. Immun. 73:2051-2060.
34. Mead, P. S., et al. 1999. Food-related illness and death in the United States. Emerg. Infect. Dis. 5:607-625.
35. Mise, K., et al. 2005. Involvement of ganglioside GM3 in G(2)/M cell cycle arrest of human monocytic cells induced by Actinobacillus actinomycetemcomitans cytolethal distending toxin. Infect. Immun. 73:4846-4852.
36. Mizuno, K., K. Takama, and S. Suzuki. 1994. Characteristics of cytotoxin produced by Campylobacter jejuni strains. Microbios 78:215-228.
37. Montfort, W., et al. 1987. The three-dimensional structure of ricin at 2.8 A. J. Biol. Chem. 262:5398-5403.
38. Nesić, D., Y. Hsu, and C. E. Stebbins. 2004. Assembly and function of a bacterial genotoxin. Nature 429:429-433.
39. Nesic, D., and C. E. Stebbins. 2005. Mechanisms of assembly and cellular interactions for the bacterial genotoxin CDT. PLoS Pathog. 1:e28.
40. Ohya, T., K. Tominaga, and M. Nakazawa. 1993. Production of cytolethal distending toxin (CLDT) by Campylobacter fetus subsp. fetus isolated from calves. J. Vet. Med. Sci. 55:507-509.
41. Okuda, J., H. Kurazono, and Y. Takeda. 1995. Distribution of the cytolethal distending toxin A gene (cdtA) among species of Shigella and Vibrio, and cloning and sequencing of the cdt gene from Shigella dysenteriae. Microb. Pathog. 18:167-172.
42. Orlandi, P. A., and P. H. Fishman. 1998. Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains. J. Cell Biol. 141:905-915.
43. Orth, D., K. Grif, M. P. Dierich, and R. Wurzner. 2006. Cytolethal distending toxins in Shiga toxin-producing Escherichia coli: alleles, serotype distribution and biological effects. J. Med. Microbiol. 55:1487-1492.
44. Parkhill, J., et al. 2000. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 403:665-668.
45. Pérès, S. Y., et al. 1997. A new cytolethal distending toxin (CDT) from Escherichia coli producing CNF2 blocks HeLa cell division in G2/M phase. Mol. Microbiol. 24:1095-1107.
46. Pickett, C. L., et al. 1996. Prevalence of cytolethal distending toxin production in Campylobacter jejuni and relatedness of Campylobacter sp. cdtB gene. Infect. Immun. 64:2070-2078.
47. Rasrinaul, L., et al. 1988. Foods as a source of enteropathogens causing childhood diarrhea in Thailand. Am. J. Trop. Med. Hyg. 39:97-102.
48. Ricci, V., et al. 2000. High cell sensitivity to Helicobacter pylori VacA toxin depends on a GPI-anchored protein and is not blocked by inhibition of the clathrin-mediated pathway of endocytosis. Mol. Biol. Cell 11:3897-3909.
49. Rosales Fritz, V. M., J. L. Daniotti, and H. J. Maccioni. 1997. Chinese hamster ovary cells lacking GM1 and GD1a synthesize gangliosides upon transfection with human GM2 synthase. Biochim. Biophys. Acta 1354:153-158.
50. Schraw, W., Y. Li, M. S. McClain, F. G. van der Goot, and T. L. Cover. 2002. Association of Helicobacter pylori vacuolating toxin (VacA) with lipid rafts. J. Biol. Chem. 277:34642-34650.
51. Shenker, B. J., et al. 2005. Induction of cell cycle arrest in lymphocytes by Actinobacillus actinomycetemcomitans cytolethal distending toxin requires three subunits for maximum activity. J. Immunol. 174:2228-2234.
52. Shenker, B. J., et al. 2007. A novel mode of action for a microbial-derived immunotoxin: the cytolethal distending toxin subunit B exhibits phosphatidylinositol 3,4,5-triphosphate phosphatase activity. J. Immunol. 178:5099-5108.
53. Simons, K., and D. Toomre. 2000. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1:31-39.
54. Simons, M., et al. 2002. Overexpression of the myelin proteolipid protein leads to accumulation of cholesterol and proteolipid protein in endosomes/ lysosomes: implications for Pelizaeus-Merzbacher disease. J. Cell Biol. 157: 327-336.
55. Sugai, M., et al. 1998. The cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin. Infect. Immun. 66:5008-5019.
56. Wolf, A. A., et al. 1998. Ganglioside structure dictates signal transduction by cholera toxin and association with caveolae-like membrane domains in polarized epithelia. J. Cell Biol. 141:917-927.
57. Wu, T. L., et al. 2002. Molecular epidemiology of nalidixic acid-resistant campylobacter isolates from humans and poultry by pulsed-field gel electrophoresis and flagellin gene analysis. Epidemiol. Infect. 129:227-231.
58. Young, V. B., K. A. Knox, and D. B. Schauer. 2000. Cytolethal distending toxin sequence and activity in the enterohepatic pathogen Helicobacter hepaticus. Infect. Immun. 68:184-191.
59. Zheng, J., J. Meng, S. Zhao, R. Singh, and W. Song. 2008. Campylobacterinduced interleukin-8 secretion in polarized human intestinal epithelial cells requires Campylobacter-secreted cytolethal distending toxin- and Toll-like receptor-mediated activation of NF-kappaB. Infect. Immun. 76:4498-4508.